SEC Company Response from ARIEL WAY INC (CIK 0001145254) — May 17, 2005
ARIEL WAY INC (CIK 0001145254)
Date: May 17, 2005 · CIK: 0001145254 · Accession: 0001144204-05-016261
AI Filing Summary & Sentiment
Show Raw Text
CORRESP
1
filename1.htm
Unassociated Document
NEW
YORK, NY
WASHINGTON,
DC
CHICAGO,
IL
STAMFORD,
CT
PARSIPPANY,
NJ
BRUSSELS,
BELGIUM
AFFILIATE
OFFICES
JAKARTA,
INDONESIA
MUMBAI,
INDIA
KELLEY
DRYE & WARREN LLP
A
LIMITED LIABILITY PARTNERSHIP
TYSONS
CORNER
8OOO
TOWERS CRESCENT DRIVE
Suite
1200
VIENNA,
VIRGINIA 22182
(703)
918-2300
FACSIMILE
(703)
918-2450
WWW.KELLEYDRYE.COM
JOHN
J. MCDONALD
(703)
918-2396
JMCDONALD@KELLEYDRYE.COM
April 4,
2005
VIA
FACSIMILE TRANSMISSION
Ms.
Melinda Kramer
Division
of Corporation Finance
Securities
and Exchange Commission
Mail Stop
0-0
450 Fifth
Street, N.W.
Washington,
D.C. 20549
Re: Netfran
Development Corp. Schedule 14C
Dear Ms.
Kramer:
I am
writing in response to the verbal comments of the Staff of the Securities
Exchange Commission (the “SEC”)
regarding the preliminary Schedule 14C filed by Netfran Development Corp. (the
“Company”) on
February 25, 2005, which were discussed during our teleconference on March 14,
2005.
For your
convenience, I have included below a paraphrasing of the Staff comments and
keyed our responses accordingly. Also, enclosed for your reference is a marked
version of the preliminary Schedule 14C showing the changes made in response to
the Staff comments.
You’ll
see that, in addition to the revisions in response to the Staff comments, I also
revised the disclosure in the Schedule 14C to include reference to the
resignation from the Company’s Board of Directors of Todd Rowley, Lloyd
Griffiths and Bob Bova, each of which occurred since the Company filed the
preliminary Schedule 14C and has been disclosed on Form 8-K’s filed by the
Company with the SEC.
In some
of our responses, the Company has agreed to change or supplement the disclosures
in the preliminary Schedule 14C that it filed. Please note that the Company is
doing so in the spirit of cooperation with the Staff, and not because it
believes that such filing is materially deficient or inaccurate. Accordingly,
any amendment to the Company’s filings to implement these changes should not be
taken as an admission that any prior disclosures were in any way
deficient.
The
Company represents that it will not assert the SEC’s review of the
Schedule 14C as a defense in any proceeding initiated by the SEC or any
person under the federal securities laws of the United States.
* * * *
*
1. SEC
Comment.
Please revise the descriptions in the “notice letter” part of the Schedule 14C
and the cover page of the “information statement” part of the Schedule 14C
concerning the amendment of the Company’s articles of amendment to provide
separately numbered items for the increase in authorized shares of common stock
and the authorization of “blank check” preferred stock.
Response.
Suggested changes have been made in the enclosed revised draft
Schedule 14C.
2. SEC
Comment.
The Schedule 14C states that stockholders collectively holding approximately 72%
of the Company’s outstanding stock signed the written consent of stockholders
authorizing the amendment to its articles of incorporation. Please describe the
process by which the consent of those stockholders was obtained.
Response. The
articles of amendment were authorized by a written consent in lieu of
stockholder meeting executed pursuant to Section 607.0704 of the Florida
Business Corporations Act, as amended, by the nine (9) persons and entities who
collectively hold approximately 72% of the Company’s outstanding stock (all of
whom are listed in the schedule entitled “Securities Ownership of Management and
Principal Stockholders” in the Schedule 14C). On February 23, 2005, Arne Dunhem,
the Company’s Chairman, President and Chief Executive Officer, held a conference
call with such stockholders in which he discussed the proposed amendment to the
Company’s articles of incorporation. Immediately thereafter, Mr. Dunhem
circulated the written consent to such stockholders by electronic mail and each
such stockholder then executed the written consent and returned a signed written
consent to the Company.
3. SEC
Comment.
The part of the Schedule 14C entitled “Change of Control” states that, among
other things, the Share Exchange Agreement transaction will result in each Ariel
Way stock option and warrant outstanding prior to the exchange transaction being
exchanged for a Company stock option or warrant (as applicable), with the
exercise price of the Company option or warrant (as applicable) equal to the
exercise price of Ariel Way option or warrant (as applicable) divided by 1.6762.
Please revise such disclosure to include the exercise price of each Ariel Way
stock option and warrant and the exercise price of each Company stock option and
warrant.
Response.
Suggested changes have been made in the enclosed revised draft
Schedule 14C.
4. SEC
Comment.
The part of the Schedule 14C entitled “Change of Control” references the
Schedule 14f-1 filed by the Company with the SEC on January 24, 2005 (concerning
the change of control of the Company’s board of directors expected to result
from the Share Exchange Agreement transaction), along with the Form 8-K filed by
the Company with the SEC on February 10, 2005 (concerning the changes made to
the Company’s officers and directors in connection with such transaction). The
Company filed a Form 8-K with the SEC on February 8, 2005 concerning completion
of the Share Exchange Agreement transaction. For completeness, this Form 8-K
should be referenced in the Schedule 14C, as well.
Response.
Suggested change has been made in the enclosed revised draft Schedule 14C.
5. SEC
Comment.
Please provide disclosure in the part of the Schedule 14C that describes the
purpose of the amendment to the Company’s articles of incorporation to increase
the amount of authorized shares of common stock and to authorize issuance of
“blank check” preferred stock concerning whether or not the Company has any
plans, proposals or arrangements regarding the issuance of any of the additional
authorized shares of common stock or any of the newly authorized shares of
“blank check” preferred stock.
Response.
Suggested changes have been made in the enclosed revised draft
Schedule 14C.
6. SEC
Comment.
If the Company will be providing an annual report to stockholders in the mailing
of the Schedule 14C, please include disclosure concerning such annual report in
the Schedule 14C.
Response. The
Company will not be providing an annual report to stockholders in the mailing of
the Schedule 14C to stockholders. As a result, no disclosure in the Schedule 14C
concerning such matters is necessary.
* * * *
*
Please
call me at (703) 918-2396, at your earliest convenience, to discuss the matters
described in this response letter.
Sincerely,
/s/ John
McDonald
John
McDonald